Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H13ClN2O2S |
| Molecular Weight | 332.805 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)C1=CC=C(C=C1)C2=CC(Cl)=NN2C3=CC=CC=C3
InChI
InChIKey=YKHNOHGHDAQJFW-UHFFFAOYSA-N
InChI=1S/C16H13ClN2O2S/c1-22(20,21)14-9-7-12(8-10-14)15-11-16(17)18-19(15)13-5-3-2-4-6-13/h2-11H,1H3
| Molecular Formula | C16H13ClN2O2S |
| Molecular Weight | 332.805 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of intravenous administration of FR122047 (a selective cyclooxygenase 1 inhibitor) and FR188582 (a selective cyclooxygenase 2 inhibitor) on prostaglandin-E2-induced aqueous flare elevation in pigmented rabbits. | 2003-12-23 |
|
| The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats. | 2001-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:36:20 GMT 2025
by
admin
on
Mon Mar 31 22:36:20 GMT 2025
|
| Record UNII |
49893L163S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
49893L163S
Created by
admin on Mon Mar 31 22:36:20 GMT 2025 , Edited by admin on Mon Mar 31 22:36:20 GMT 2025
|
PRIMARY | |||
|
189699-82-9
Created by
admin on Mon Mar 31 22:36:20 GMT 2025 , Edited by admin on Mon Mar 31 22:36:20 GMT 2025
|
PRIMARY | |||
|
9840588
Created by
admin on Mon Mar 31 22:36:20 GMT 2025 , Edited by admin on Mon Mar 31 22:36:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |